Global Triptorelin Acetate Sales Market Report 2020

SKU ID : QYR-16610754 | Publishing Date : 23-Oct-2020 | No. of pages : 135

Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).
The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;

Market Analysis and Insights: Global Triptorelin Acetate Market
The global Triptorelin Acetate market size is projected to reach US$ 649.2 million by 2026, from US$ 516 million in 2020, at a CAGR of 3.9% during 2021-2026.

Global Triptorelin Acetate Scope and Market Size
The global Triptorelin Acetate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Triptorelin Acetate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Triptorelin Acetate market is segmented into
0.1 mg
3 mg
11.25 mg

Segment by Application, the Triptorelin Acetate market is segmented into
Male Disease
Female Disease

The Triptorelin Acetate market is analysed and market size information is provided by regions (countries). Segment by Application, the Triptorelin Acetate market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Triptorelin Acetate Market Share Analysis
Triptorelin Acetate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Triptorelin Acetate business, the date to enter into the Triptorelin Acetate market, Triptorelin Acetate product introduction, recent developments, etc.

The major vendors covered:
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports